Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Publish with us
About the journal
Meet the editors
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Publish with us
About the journal
Meet the editors
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 1, Issue 1
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Research
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs
Online download statistics by month:
Online download statistics by month: December 2022 to May 2023
Abstract
Full
Pdf
Dec 2022
834
831
192
Jan 2023
317
323
145
Feb 2023
230
228
78
Mar 2023
179
180
55
Apr 2023
112
111
51
May 2023
186
191
44
Total
1858
1864
565
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF